Australia's most trusted
source of pharma news
Posted 6 August 2025 AM
Dennis Bastas has sold part of his healthcare empire in a historic deal that provides access to more than $1 billion which will be used to bankroll major growth in the Australian medicines sector.
DBG Health, the parent company of Arrotex Pharmaceuticals, has entered into a definitive agreement for a significant minority investment from US merchant bank BDT & MSD Partners, which has connections to Michael Dell of Dell Computers. The bank specialises in working with growth-minded founders and their families.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.